UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 28, 2024
Accession Number:
0001193125-24-075257
Submission Type:
POS AM
CIK:
0001042074
Company Name:
CymaBay Therapeutics, Inc.
File Number:
333-229082